PMID: 15228157Jul 2, 2004Paper

Therapeutic monitoring of new antipsychotic drugs

Therapeutic Drug Monitoring
C HiemkeMatthias J Müller

Abstract

Typical antipsychotic drugs qualify for therapeutic drug monitoring (TDM) primarily for the following reasons: control of compliance and avoidance of extrapyramidal side effects by keeping chronic exposure to minimal effective blood levels. For the atypical antipsychotic clozapine, drug safety is another reason to use TDM. With regard to the new antipsychotics risperidone, olanzapine, quetiapine, amisulpride, ziprasidone, and aripiprazole, which have been introduced in the clinic during the last few years, the rationale to use TDM is a matter of debate. Positron emission tomography (PET), which enables measurement of the occupancy of dopamine D2 receptors, revealed that receptor occupancy correlated better with plasma concentrations than with doses of the antipsychotics. Regarding plasma levels related to therapeutic effects, optimal concentrations have been established for clozapine (350-600 ng/mL), risperidone (20-60 ng/mL), and olanzapine (20-80 ng/mL) but not for the other new antipsychotics. Studies that included analyses of drug levels in blood reported mean concentrations of 68 ng/mL for quetiapine and 317 ng/mL for amisulpride under therapeutic doses of the antipsychotic drugs. For ziprasidone or aripriprazole, data on ...Continue Reading

References

Mar 14, 1991·The New England Journal of Medicine·R J Baldessarini, F R Frankenburg
Jan 1, 1995·Schizophrenia Bulletin·R W Buchanan
Jan 1, 1996·The Psychiatric Quarterly·T B Cooper
Feb 1, 1997·Clinical Pharmacokinetics·D J Freeman, L K Oyewumi
Feb 1, 1997·International Clinical Psychopharmacology·C A TammingaK B Kashkin
Aug 1, 1997·Therapeutic Drug Monitoring·H WeigmannC Hiemke
Jul 11, 1998·The American Journal of Psychiatry·S KapurS Houle
Aug 26, 1998·Therapeutic Drug Monitoring·O V OlesenK Linnet
May 2, 2000·Psychopharmacology·P B FitzgeraldR B Zipursky
Jun 13, 2000·Therapeutic Drug Monitoring·D R UgesJ Versteege
Jun 28, 2000·Biopharmaceutics & Drug Disposition·M AravagiriS R Marder
Oct 14, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·P CarrièreT Lempérière
Apr 21, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·O GefvertL Lindström
Jun 2, 2001·Journal of Clinical Psychopharmacology·I GaertnerK Dietz
Jul 31, 2001·Therapeutic Drug Monitoring·R A SweetB G Pollock
Oct 5, 2001·Expert Opinion on Pharmacotherapy·P E KeckL M Arnold
Nov 13, 2001·Fortschritte der Neurologie-Psychiatrie·M L RaoUNKNOWN TDM Arbeitsgruppe Der AGNP
May 1, 2002·International Clinical Psychopharmacology·D F ZullinoP Baumann
Jul 3, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Fuji YokoiDean F Wong
Nov 28, 2002·Journal of Clinical Psychopharmacology·Matthias J MüllerUNKNOWN Amisulpride Study Group
Dec 11, 2002·Expert Opinion on Pharmacotherapy·Paul J Goodnick, Jason M Jerry
Dec 31, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Julia SachseChristoph Hiemke
Jan 28, 2003·Therapeutic Drug Monitoring·Marianne Gex-FabryLuc P Balant
Feb 5, 2003·International Journal of Clinical Pharmacology and Therapeutics·S UlrichF P Meyer
Jun 5, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David A ShapiroRichard Mailman
Jul 31, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Christine FrahnertKatja Grasmäder

❮ Previous
Next ❯

Citations

Apr 28, 2007·Der Anaesthesist·S G SakkaE Hüttemann
Aug 19, 2007·Der Nervenarzt·C BrandtB Pohlmann-Eden
May 24, 2007·Analytical and Bioanalytical Chemistry·Franck Saint-MarcouxPierre Marquet
Jan 16, 2008·European Journal of Clinical Pharmacology·Christoph Hiemke
May 15, 2008·European Journal of Clinical Pharmacology·Yan-Gang ZhouHuan-De Li
Apr 12, 2008·European Archives of Psychiatry and Clinical Neuroscience·Christoph Hiemke
Dec 11, 2008·Clinical Drug Investigation·E E M BrouwersA D R Huitema
Aug 12, 2009·Pharmacogenomics·Giorgio ConsoliAntonello Di Paolo
Jan 1, 2008·International Journal of Psychiatry in Clinical Practice·Daniel M BennettColin Gray
Jun 19, 2013·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Malin Bartos, Kai Knudsen
Mar 3, 2012·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Lukas Lannemyr, Kai Knudsen
Sep 2, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Eveline Jaquenoud SirotPierre Baumann
Aug 13, 2011·Forensic Science International : Synergy·D StanworthR J Flanagan
Nov 26, 2010·Analytica Chimica Acta·Seyed Ahmad MohajeriMehdi Rajabnia Khansari
Oct 28, 2008·European Psychiatry : the Journal of the Association of European Psychiatrists·Friederike VogelChristoph Hiemke
Jun 17, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Sheila BottsJose de Leon
Nov 9, 2015·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Trine Naalsund AndreassenOlav Spigset
Oct 7, 2008·Basic & Clinical Pharmacology & Toxicology·Jun-Sheng WangC Lindsay Devane
Mar 27, 2007·Journal of Clinical Pharmacy and Therapeutics·W MahatthanatrakulM Sunbhanich
Dec 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rossella MedoriGerhard Gründer
Dec 6, 2005·Journal of Psychiatric Research·Matthias J MüllerChristoph Hiemke
May 4, 2016·Clinical Pharmacology in Drug Development·Sireen A R ShilbayehHartmut Derendorf
Mar 25, 2015·Journal of Child and Adolescent Psychopharmacology·Zachary WhitneyAlasdair M Barr
Mar 1, 2008·Journal of Psychopharmacology·A M CatafauUNKNOWN Barcelona Clinical Imaging in Psychiatry Group
Oct 14, 2006·Therapeutic Drug Monitoring·Thein Z OoManoranjenni Chetty
Mar 30, 2005·Therapeutic Drug Monitoring·Julia SachseChristoph Hiemke
Jan 29, 2008·Therapeutic Drug Monitoring·Jesús HermidaJ Carlos Tutor
Apr 10, 2007·European Psychiatry : the Journal of the Association of European Psychiatrists·Luca PaniGiorgio Marchese

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Pharmacopsychiatry
P BaumannArbeitsge-meinschaft fur neuropsychopharmakologie und pharmakopsychiatrie
The New England Journal of Medicine
Jeffrey A LiebermanClinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
© 2022 Meta ULC. All rights reserved